Nectar Lifesciences Limited (NECLIFE.NS) NSE
12.00
-0.01(-0.08%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.4B |
| Enterprise Value | 11.03B |
| P/E Ratio | -0.76 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.38 |
| Price/Book Ratio | 0.38 |
| Enterprise/Revenue | 1.01 |
| Enterprise/EBITDA | -5.59 |
Fiscal Year
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | -0.5 |
| Operating Margin | -0.35 |
Management Effectiveness
| Return On Assets | -0.2 |
| Return On Equity | -0.38 |
Income Statement
| Revenue | 16.7B |
| Revenue/Share | 31.9 |
| Gross Profit | 3.02B |
| EBITDA | -245.66M |
| Net Income | -1.14B |
| Diluted EPS | -5.07 |
Balance Sheet
| Total Cash | 139.72M |
| Total Cash/Share | 0.29 |
| Total Debt | 4.59B |
| Total Debt/Equity | 0.64 |
| Current Ratio | 0.36 |
| Book Value Per Share | 31.97 |
Price History
| 52-Week Change | -51.9 |
| 52-Week High | 25.5 |
| 52-Week Low | 9.3 |
| Moving Average 50 Days | 11.86 |
| Moving Average 200 Days | 14.36 |
Statistics
| Average Volume | 430,542 |
| Shares Outstanding | 224.26M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
| Last Split Date | November 12, 2008 |
